Michaela Granfors, Helena Åkerud, Anna Berglund, Johan Skogö, Inger Sundström-Poromaa, and Anna-Karin Wikström
|
|
- Candace Mills
- 5 years ago
- Views:
Transcription
1 ORIGINAL ARTICLE Endocrine Care Thyroid Testing and Management of Hypothyroidism During Pregnancy: A Population-based Study Michaela Granfors, Helena Åkerud, Anna Berglund, Johan Skogö, Inger Sundström-Poromaa, and Anna-Karin Wikström Department of Women s and Children s Health and National Centre for Knowledge on Men s Violence Against Women, Uppsala University, SE Uppsala, Sweden Context: There are international guidelines on thyroid function testing and management of hypothyroidism during pregnancy. Few studies have evaluated how they are implemented into clinical practice. Objective: In this descriptive study, we assessed the implementation of international guidelines in this field into local guidelines and also into clinical practice. Design and Participants: In a nationwide survey, all guidelines in Sweden were collected (n 29), and the adherence of the local guidelines to The Endocrine Society Guidelines 2007 was evaluated. In a follow-up in 1 district, 5254 pregnant women with an estimated date of delivery between January 1, 2009, and December 31, 2011, were included for subsequent review of their medical reports. Results: All but 1 district had guidelines on the subject. All local guidelines included fewer than the 10 listed reasons for thyroid testing recommended by The Endocrine Society Guidelines. Furthermore, most guidelines recommended additional types of thyroid function tests to TSH sampling and lower trimester-specific TSH upper reference limits for women on levothyroxine (P.001). In the follow-up, the thyroid testing rate was 20%, with an overall frequency of women with trimester-specific elevated TSH of 18.5%. More than half of the women (50.9%) who were on levothyroxine at conception had an elevated TSH level at thyroid testing according to The Endocrine Society Guidelines. Conclusions: The local guidelines are variable and poorly compliant with international guidelines. Performance of thyroid testing is not optimal, and rates of elevated TSH at testing are extremely high in subgroups. (J Clin Endocrinol Metab 98: , 2013) Hypothyroidism is one of the most common endocrine disorders in women of reproductive age (1). The prevalence of overt hypothyroidism during pregnancy has commonly been estimated to be 0.3% 0.5%, but in addition, 2% 3% of pregnant women may suffer from subclinical hypothyroidism (2 4). However, the prevalence of hypothyroidism is dependent on several factors, and other studies have described prevalence as high as 12.3% (5). While overt hypothyroidism is defined as a serum TSH level above the defined upper limit of the reference range, in combination with a serum free T 4 below the lower limit of the reference range, subclinical hypothyroidism is defined as elevated TSH, combined with normal T 4 levels (6). Iodine deficiency is the most common cause of hypothyroidism worldwide (7), but in areas of iodine sufficiency, as in Sweden, chronic autoimmune thyroiditis is the main cause of hypothyroidism (8). Other causes of hypothyroidism include previous thyroidectomy or ablative radioiodine therapy, but secondary (pituitary) and tertiary (hypothalamic) causes of hypothyroidism are rare. Overt hypothyroidism, and, to some extent, even subclinical hypothyroidism, is associated with adverse effects ISSN Print X ISSN Online Printed in U.S.A. Copyright 2013 by The Endocrine Society Received February 4, Accepted May 16, First Published Online May 20, 2013 Abbreviation: TPOAb, thyroid peroxidase antibody. doi: /jc J Clin Endocrinol Metab, July 2013, 98(7): jcem.endojournals.org 2687
2 2688 Granfors et al Thyroid Testing During Pregnancy J Clin Endocrinol Metab, July 2013, 98(7): on pregnancy and neonatal outcome as well as on fetal brain development (1). It is generally accepted that overt hypothyroidism should be treated with levothyroxine during pregnancy, whereas for of subclinical hypothyroidism, current evidence is insufficient (9). Moreover, how to test for hypothyroidism is a matter of controversy worldwide (7, 10, 11). In recent years, 2 evidence-based international guidelines have been published: The Endocrine Society Guidelines from 2007, with a recent update in August 2012 (2, 12), and the guidelines from the American Thyroid Association from 2011 (13). Even so, a recent European survey demonstrated a lack of consensus in thyroid testing and the of hypothyroidism during pregnancy (14). The aims of this study were to determine the adherence of nationwide guidelines to international guidelines on thyroid testing and management of hypothyroidism during pregnancy. Second, we aimed to analyze the final degree of implementation of guidelines into everyday clinical practice. Subjects and Methods National survey on adherence to international guidelines In Sweden, there were no national recommendations concerning thyroid testing or of maternal hypothyroidism during pregnancy. To identify the local guidelines, a nationwide survey was conducted in 2011 and completed in Antenatal care in Sweden is standardized, free of charge, and decentralized to maternity care areas (n 41). Within each maternity care area, a consultant in obstetrics is responsible for development and implementation of guidelines. All maternity care consultants (n 41) were asked by whether they had guidelines concerning thyroid testing and management of hypothyroidism during pregnancy and, if so, to provide the guidelines. All maternity care consultants replied after 1 or more reminders. The guidelines were analyzed with respect to 4 different aspects: 1) the degree of adherence to The Endocrine Society Guidelines 2007 (2), where 10 high-risk groups as reasons for thyroid testing are described, and the proportion of these reasons that were found in the local guidelines was calculated; 2) recommended thyroid function tests; 3) the trimester-specific TSH upper reference limit for intervention with levothyroxine; and 4) the trimester-specific TSH upper reference limit for monitoring women on with levothyroxine. Follow-up: implementation of guidelines into clinical practice A total of 5254 pregnant women from Uppsala county with an ultrasound-estimated date of delivery between January 1, 2009, and December 31, 2011, were included. Pregnant women, 18 years or older, Swedish-speaking and without blood-borne from the whole of Uppsala county, were approached for participation in a study cohort when attending the second-trimester routine ultrasound screening at 17 to 18 weeks of gestation. Participation in this study cohort included both biobank research and clinical approaches, such as, for example, medical record reviews. Inquiry for participation was done at random when the research nurse was available. Approximately 30% of the respondents declined participation, mainly due to lack of time or fear of blood or needles, because blood samples were collected to be used not in this but in other clinical studies. During our inclusion period, there were about deliveries in the district of Uppsala county. Thus, nearly half of the women from the whole district, pregnant in the second trimester at approach for participation, were included in our study. The included women s medical reports, including any thyroid function tests taken in clinical practice, were reviewed between February and May 2012 concerning: 1) if and when thyroid testing had been performed, and in case of repeated testing, only the first TSH analyzed during the pregnancy (from gestational week 4 0 d until delivery) was considered and defined as thyroid testing; 2) the specified reasons for thyroid testing; and 3) the frequency of women with trimester-specific elevated TSH, overall, and within the groups with specified reasons for thyroid testing. Serum TSH levels were measured by an electrochemiluminescent immunoassay (Cobas E601; Roche Diagnostics, Basel, Switzerland; normal range for nonpregnant women, miu/l). According to international guidelines, we used the trimesterspecific TSH upper reference limits for intervention or dose adjustment of levothyroxine of 2.5 miu/l in the first trimester and 3.0 miu/l in the second and third trimester for the follow-up (2, 12, 13). Pregnancy trimesters were defined as follows: first trimester until 13 completed gestational weeks, second trimester gestational week 14 to 27, and third trimester 28 completed gestational weeks or later. In the guidelines from the district, valid during the entire follow-up period, 5 reasons for thyroid testing were found: personal history of thyroid dysfunction with or without ongoing levothyroxine, family history of thyroid dysfunction, goiter, type 1 diabetes, and other autoimmune s (Morbus Addison, celiac, and atrophic gastritis with vitamin B12 deficiency were specified). The participating women gave written informed consent and the Ethical Review Board at Uppsala University, Sweden, approved the study. The statistical software package SPSS including 1-sample t tests was used for all data analyses. Results National survey on adherence to international guidelines Forty of 41 maternity care areas had written guidelines on thyroid testing and management of hypothyroidism during pregnancy. In some parts of Sweden, groups of maternity care areas had chosen to use common guidelines. All in all, 29 different guidelines were available. We defined the areas with common or unique local guidelines as districts (n 29). All districts recommended thyroid function testing as targeted case finding in high-risk women.
3 doi: /jc jcem.endojournals.org 2689 The 10 reasons for thyroid testing identified in The Endocrine Society Guidelines 2007 and the implementation of these thyroid testing reasons in the Swedish local guidelines are displayed in Table 1. The most commonly stated reasons for thyroid testing were personal and/or family history of thyroid (both 86.3%). Of the local guidelines, only 17.2% recommended thyroid testing solely with TSH. Most local guidelines (82.8%) recommended additional analyses such as free T 4 (75.9%), thyroid peroxidase antibodies (TPOAbs) (37.9%), free T 3 (6.9%), and TSH receptor antibodies (6.9%). In Figure 1A, recommended first-trimester TSH upper reference limits for intervention with levothyroxine are shown. Approximately 50% of the local guidelines advocated intervention with levothyroxine when first-trimester TSH exceeded 2.5 miu/l, which was in accordance with The Endocrine Society Guidelines (P.39) (2). In Figure 1, B and C, recommended trimester TSH upper reference limits for women on levothyroxine are shown. The TSH upper reference limits recommended by the local guidelines were significantly lower than those recommended by The Endocrine Society Guidelines (2), with reference to both the first trimester (P.001) and second and third trimester (P.001). Only 3 of the 29 local guidelines were completely consistent with the international guidelines with respect to TSH trimester-specific upper reference limits for women with ongoing levothyroxine, recommending both 2.5 miu/l for the first and 3.0 miu/l for the second and third Table 1. Adherence of Local Guidelines (n 29) to The Endocrine Society Guidelines 2007 Concerning Reasons for Thyroid Testing Numbers (n) and Proportion (%) of Swedish Guidelines Listing the Reason Reason for Thyroid Testing Number Proportion, % Personal history of thyroid Family history of thyroid Goiter Type 1 diabetes Other autoimmune disorders Symptoms or clinical signs History of miscarriage or preterm delivery Infertility Previous head or neck irradiation Thyroid antibodies (when 0 0 known) trimester of pregnancy as TSH trimester-specific upper reference limits. Guidelines from 2 districts are not represented in the figure. In 1 of these districts, referral of hypothyroid women to an endocrinology department was recommended without indicating any TSH upper reference limit. In the other district, the upper TSH limit varied depending on the presence of TPOAbs. For women already on levothyroxine at conception, The Endocrine Society Guidelines 2007 state that the levothyroxine dose usually needs to be incremented by 4 to 6 weeks of gestation and may require a 30% to 50% increase in dosage (2). The latter Guidelines of the American Thyroid Association from 2011 clearly recommend an empiric 25% to 30% dose increase as soon as pregnancy has been confirmed (13). None of the local guidelines contained this recommendation. Follow-up: implementation of guidelines into clinical practice In the follow-up population, the thyroid testing rate was 20.1%. Most tested women (65.7%) had their tests taken in the first trimester, whereas 23.9% and 10.4% were tested in the second and third trimester, respectively. Most of the 163 women who were on levothyroxine at the time of conception were tested in the first trimester of pregnancy (91.4%). Only in 4 of those 163 women was the dose of levothyroxine increased at an early stage of pregnancy, before thyroid testing. The reasons for thyroid testing at any time during pregnancy are shown in Table 2. The most common reason was family history of thyroid (33.5%). Although not recommended in the local guidelines of the district, thyroid testing was (according to the medical records review) even performed for the remaining 5 testing reasons stated in The Endocrine Society Guidelines (2). Of those 5 reasons, symptoms or clinical signs were predominant as the reason for thyroid testing. The reasons for thyroid testing varied during different trimesters of pregnancy. Although personal or family history of thyroid were the most common reasons for thyroid testing in the first trimester (28.9% and 43.6%, respectively), symptoms or clinical signs were the most common reasons for thyroid testing in the second and third trimester (42.1% and 56.4%, respectively). However, the reason for thyroid testing was often unclear when tests were taken in the second and third trimester (25.8% and 24.5%, respectively). The overall frequency of women with trimester-specific elevated TSH was 18.5% in the follow-up population. In Table 3, the proportion of women with trimesterspecific elevated TSH in relation to the respective reason for thyroid testing is shown. More than half of women
4 2690 Granfors et al Thyroid Testing During Pregnancy J Clin Endocrinol Metab, July 2013, 98(7): Figure 1. TSH upper reference limits according to the local guidelines. A, First-trimester limit for intervention with levothyroxine (mean TSH 2.59 miu/l; 95% confidence interval [CI] miu/l). B, First-trimester limit for women on with levothyroxine (mean TSH 2.22 miu/l; 95% CI miu/l). C, Second- and third-trimester limit for women on with levothyroxine (mean TSH 2.31 miu/ L; 95% CI miu/l). who were already on levothyroxine at conception had trimester-specific elevated TSH when first tested (50.9% of cases). Discussion The local guidelines for thyroid testing and management of hypothyroidism during pregnancy differed in several aspects from the international guidelines (2). In the followup, we found a thyroid testing rate of 20.1%, with an overall frequency of women with trimester-specific elevated TSH of 18.5%. More disturbingly, half of the women who were on levothyroxine at the time of conception had an elevated TSH level at thyroid testing (50.9%). In the national survey, the number of reasons for which thyroid testing was advised varied among the guidelines, and no guidelines included all 10 reasons stated by The Endocrine Society (2). Instead, thyroid testing was advised for between 2 and 7 reasons. In addition, more than 80% of the local guidelines advocated thyroid function testing with additional tests to TSH sampling. This is in contrast to The Endocrine Society Guidelines and the guidelines from the American Thyroid Association (2, 13), both of which recommend further thyroid tests only in case of abnormal TSH. At present, it thus appears as if too few pregnant women are advised for thyroid testing with too many thyroid function tests. In compliance with the international guidelines, most local guidelines recommend levothyroxine when TSH is above the upper reference limit of 2.5 miu/l in the first trimester. Surprisingly, most of the Swedish guidelines advocate lower target TSH levels for women on levothyroxine than the international guidelines (2, 12, 13). The rationale for the recommendations in the
5 doi: /jc jcem.endojournals.org 2691 Table 2. Reasons for Thyroid Testing in the Follow-up Population Reason for Thyroid Testing Number Proportion, % Personal history of thyroid Ongoing levothyroxine No ongoing levothyroxine Family history of thyroid Goiter Type 1 diabetes Other autoimmune disorders Symptoms or clinical signs History of miscarriage or preterm delivery Infertility Previous head or neck irradiation Thyroid antibodies (when known) Blood sampling as part of a medical investigation Unclear reason Total local guidelines and their implications for pregnancy outcomes are unclear. In our follow-up in 1 of the districts, 5 of 10 reasons for thyroid testing from The Endocrine Society Guidelines 2007 were recommended. Interestingly, in clinical practice, all of the 10 reasons were applied. In addition, 16.8% of the tested women in our follow-up population were tested for reasons that were unclear. Moreover, our results raise suspicions that, in clinical practice, women with risk factors for hypothyroidism during pregnancy are poorly identified and tested. The thyroid testing rate in the district (20.1%) was in accordance with a study from Negro et al (15) who classified 20.5% of their study population in the first trimester of pregnancy to be at high risk for thyroid. However, Negro and colleagues (15) did not include women with personal history of thyroid, women with known TPOAbs, or women with infertility. When we exclude women tested due to personal history of thyroid (n 226), known TPOAbs (n 3), or infertility (n 5) and women screened for unknown reasons (n 178), the thyroid testing rate in our follow-up within 1 district dropped to 12.2%. Finally, when only first-trimester thyroid testing is considered (excluding women tested in the second and third trimester; n 248), the thyroid testing rate in the first trimester was as low as 7.5%. In the follow-up, we found elevated TSH levels at thyroid testing in half of women who were on levothyroxine at conception. Untreated, or insufficiently Table 3. Women With Trimester-Specific Elevated TSH in Relation to Reason for Thyroid Testing in the Followup Population Reason for Thyroid Testing Number (Total) Proportion,% Personal history of thyroid Ongoing levothyroxine 83 (163) 50.9 No ongoing levothyroxine 15 (60) 25.0 Family history of thyroid 51 (353) 14.4 Goiter 2 (14) 14.3 Type 1 diabetes 2 (8) 25.0 Other autoimmune disorders 1 (12) 8.3 Symptoms or clinical signs 23 (226) 10.2 History of miscarriage or 2 (16) 12.5 preterm delivery Infertility 2 (5) 40.0 Previous head or neck 0 (2) 0 irradiation Thyroid antibodies (when 1 (3) 33.3 known) Blood sampling as part of a 6 (15) 40.0 medical investigation Unclear reason 7 (177) 4.0 treated, overt and subclinical hypothyroidism in early stages of pregnancy may have detrimental effects on pregnancy outcome and on the neuropsychological development of the unborn child (9, 16 20). Surprisingly, none of the Swedish guidelines contained The Endocrine Society Guideline s recommendation to consider an increment of the levothyroxine dose by 4 to 6 weeks of gestation (2), probably resulting in many insufficiently treated hypothyroid women in the early stages of pregnancy. One major strength of our study is the populationbased design. In the survey, the response rate was 100%, and due to the organization of the healthcare system, the local guidelines are applied nationwide to the whole pregnant population of the country. Furthermore, in contrast to earlier studies, we were able to show how subsequent thyroid testing was performed in clinical practice in addition to a comprehensive survey (14, 21). A limitation of our study is its descriptive nature. In addition, as a consequence of the study design, we do not know the TSH levels of the untested women. Moreover, less than half of the pregnant women at 17 to 18 weeks of gestation from the district were included in the follow-up. However, the sample is probably representative for the population of the district, because inquiry for participation was done at random and declined participation was mainly due to lack of time or fear of blood or needles, which are unlikely markers for thyroid.
6 2692 Granfors et al Thyroid Testing During Pregnancy J Clin Endocrinol Metab, July 2013, 98(7): Our results show that the local guidelines were not in compliance with the guidelines from The Endocrine Society (2), and in clinical practice, thyroid testing and of hypothyroidism were suboptimal. In a recent report from the United States, awareness of The Endocrine Society Guidelines had a significant positive impact on patient care with regard to thyroid testing and management of thyroid during pregnancy (22). However, only 11.5% of providers in the American survey had read The Endocrine Society Guidelines. This highlights the importance of implementing evidence-based guidelines. It is highly probable that the international guidelines are too extensive to be studied by a significant proportion of caregivers (2, 12, 13). As a consequence, a 2-step procedure seems to be adequate: establishment of short but concise evidence-based guidelines with local or national modifications for differences in maternal healthcare and subsequent efforts to improve the implementation of these guidelines. These efforts should be of a multilevel approach, involving interventions in the policy-making, managerial, educational, and practical areas (23). Finally, follow-up of adherence to guidelines is essential and should be used as a marker of high-quality care. In conclusion, on a nationwide basis, local guidelines on thyroid testing and of hypothyroidism during pregnancy were variable and poorly compliant with international guidelines. Performance of thyroid testing in clinical practice was not optimal, and rates of elevated TSH at thyroid testing were extremely high in women already on levothyroxine at the time of conception. Improvements are desirable. Acknowledgments Address all correspondence and requests for reprints to: Michaela Granfors, Department of Women s and Children s Health, University Hospital, SE Uppsala, Sweden. E- mail: michaela.granfors@kbh.uu.se. This work was supported by grants from the Gillbergska Foundation, and by grants from the Department of Women s and Children s Health, Uppsala University Hospital, Uppsala, Sweden. Disclosure Summary: The authors have nothing to disclose. References 1. Reid SM, Middleton P, Cossich MC, Crowther CA. Interventions for clinical and subclinical hypothyroidism in pregnancy. Cochrane Database Syst Rev. 2010;7:CD Abalovich M, Amino N, Barbour LA, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2007;92: S1 S Casey BM, Leveno KJ. Thyroid in pregnancy. Obstet Gynecol. 2006;108: Casey BM, Dashe JS, Wells CE, et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol. 2005;105: Altomare M, La Vignera S, Asero P, et al. High prevalence of thyroid dysfunction in pregnant women [published online October 22, 2012]. J Endocrinol Invest. doi: / Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid : scientific review and guidelines for diagnosis and management. JAMA. 2004;291: Glinoer D, Abalovich M. Unresolved questions in managing hypothyroidism during pregnancy. BMJ. 2007;335: Allan WC, Haddow JE, Palomaki GE, et al. Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen. 2000;7: Vissenberg R, van den Boogaard E, van Wely M, et al. Treatment of thyroid disorders before conception and in early pregnancy: a systematic review. Hum Reprod Update. 2012;18: Lazarus JH. Screening for thyroid dysfunction in pregnancy: is it worthwhile? J Thyroid Res. 2011;2011: Vila L, Velasco I, González S, et al. Detection of thyroid dysfunction in pregnant women: universal screening is justified. Endocrinol Nutr. 2012;59: De Groot L, Abalovich M, Alexander EK, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97: Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid during pregnancy and postpartum. Thyroid. 2011;21: Vaidya B, Hubalewska-Dydejczyk A, Laurberg P, Negro R, Vermiglio F, Poppe K. Treatment and screening of hypothyroidism in pregnancy: results of a European survey. Eur J Endocrinol. 2012; 166: Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro- Green A. Universal screening versus case finding for detection and of thyroid hormonal dysfunction during pregnancy. J Clin Endocrinol Metab. 2010;95: Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 1999;341: Klein RZ, Sargent JD, Larsen PR, Waisbren SE, Haddow JE, Mitchell ML. Relation of severity of maternal hypothyroidism to cognitive development of offspring. J Med Screen. 2001;8: Abalovich M, Gutierrez S, Alcaraz G, Maccallini G, Garcia A, Levalle O. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid. 2002;12: Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro- Green A. Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy. J Clin Endocrinol Metab. 2010;95:E44 E van den Boogaard E, Vissenberg R, Land JA, et al. Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review. Hum Reprod Update. 2011;17: Haddow JE, McClain MR, Palomaki GE, Kloza EM, Williams J. Screening for thyroid disorders during pregnancy: results of a survey in Maine. Am J Obstet Gynecol. 2006;194: Haymart MR. The role of clinical guidelines in patient care: thyroid hormone replacement in women of reproductive age. Thyroid. 2010;20: Ubbink DT, Guyatt GH, Vermeulen H. Framework of policy recommendations for implementation of evidence-based practice: a systematic scoping review. BMJ Open. 2013;3:e
Whether to apply targeted or universal testing for
Original Research Targeted Thyroid Testing During Pregnancy in Clinical Practice Michaela Granfors, MD, Helena Åkerud, MD, Johan Skogö, MD, Mats Stridsberg, MD, Anna-Karin Wikström, MD, and Inger Sundström-Poromaa,
More informationClinical THYROIDOLOGY
Clinical THYROIDOLOGY Editor-in Chief Jerome M. Hershman, MD Distinguished Professor of Medicine UCLA School of Medicine and VA Greater Los Angeles Healthcare System Endocrinology 111D, 11301 Wilshire
More informationClinical efficacy of therapeutic intervention for subclinical hypothyroidism during pregnancy
Clinical efficacy of therapeutic intervention for subclinical hypothyroidism during pregnancy R. Ju 1, L. Lin 2, Y. Long 2, J. Zhang 2 and J. Huang 2 1 Gynaecology and Obstetrics Department, Beijing Chuiyangliu
More informationMonitoring Levothyroxine Dose during Pregnancy: A Prospective Study
American Journal of Infectious Diseases 7 (3): 75-79, 2011 ISSN 1553-6203 2011 Science Publications Monitoring Levothyroxine Dose during Pregnancy: A Prospective Study 1 Juhi Agarwal, 1 Sirimavo Nair and
More informationIncreased Pregnancy Loss Rate in Thyroid Antibody Negative Women with TSH Levels between 2.5 and 5.0 in the First Trimester of Pregnancy
JCEM ONLINE Brief Report Endocrine Care Increased Pregnancy Loss Rate in Thyroid Antibody Negative Women with TSH Levels between 2.5 and 5.0 in the First Trimester of Pregnancy Roberto Negro, Alan Schwartz,
More informationA descriptive study of the prevalence of hypothyroidism among antenatal women and foetal outcome in treated hypothyroid women
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Prasad DR et al. Int J Reprod Contracept Obstet Gynecol. 2016 Jun;5(6):1892-1896 www.ijrcog.org pissn 2320-1770 eissn 2320-1789
More informationManagement of gestational hypothyroidism: results of a Brazilian survey
original article Management of gestational hypothyroidism: results of a Brazilian survey 1 Endocrinologia e Metabolismo, Pontifícia Universidade Católica de Campinas (PUC-Campinas). Laboratório de Genética
More informationEvaluation of maternal thyroid function during pregnancy: the importance of using gestational age-specific reference intervals
European Journal of Endocrinology (2007) 157 509 514 ISSN 0804-4643 CLINICAL STUDY Evaluation of maternal thyroid function during pregnancy: the importance of using gestational age-specific reference intervals
More informationShould every pregnant woman be screened for thyroid disease?
Should every pregnant woman be screened for thyroid disease? Tal Biron-Shental Rinat Gabbay-Benziv Is there a debate? Thyroid screening Guidelines Targeted case finding criteria Age > 30 years Personal
More informationTSH Levels and Risk of Miscarriage in Women on Long-Term Levothyroxine: A Community-Based Study
ORIGINAL Endocrine ARTICLE Research TSH Levels and Risk of Miscarriage in Women on Long-Term Levothyroxine: A Community-Based Study Peter N. Taylor, Caroline Minassian, Anis Rehman, Ahmed Iqbal, Mohd Shazli
More informationLothian Guidance for Diagnosis and Management of Thyroid Dysfunction in Pregnancy
Lothian Guidance for Diagnosis and Management of Thyroid Dysfunction in Pregnancy Early diagnosis and good management of maternal thyroid dysfunction are essential to ensure minimal adverse effects on
More informationThis is the author s final accepted version.
Carty, D. M., Doogan, F., Welsh, P., Dominiczak, A. F., and Delles, C. (2017) Thyroid stimulating hormone (TSH) 2.5mU/l in early pregnancy: prevalence and subsequent outcomes. European Journal of Obstetrics
More informationThyroid diseases in pregnancy: The importance of anamnesis
Original Article Thyroid diseases in pregnancy: The importance of anamnesis Necati Bulmus 1, Isik Ustuner 2, Emine Seda Guvendag Guven 3, Figen Kir Sahin 4, Senol Senturk 5, Serap Baydur Sahin 6 Open Access
More informationHypothyroidism in pregnancy. Nor Shaffinaz Yusoff Azmi Jabatan Perubatan Hospital Sultanah Bahiyah Kedah
Hypothyroidism in pregnancy Nor Shaffinaz Yusoff Azmi Jabatan Perubatan Hospital Sultanah Bahiyah Kedah Agenda 1. Epidemiology and clinical characteristics of maternal hypothyroidism 2. Prevention and
More informationLothian Guidance for Diagnosis and Management of Thyroid Dysfunction in Pregnancy.
Lothian Guidance for Diagnosis and Management of Thyroid Dysfunction in Pregnancy. Early diagnosis and good management of maternal thyroid dysfunction is essential to ensure minimal adverse effects on
More informationScreening and management of hypothyroidism in pregnancy: Results of an Asian survey
Endocrine Journal 2014, 61 (7), 697-704 Original Screening and management of hypothyroidism in pregnancy: Results of an Asian survey Fereidoun Azizi 1), Atieh Amouzegar 1), Ladan Mehran 1), Shahram Alamdari
More informationPrevalence of thyroid disorder in pregnancy and pregnancy outcome
Original Research Article Prevalence of thyroid disorder in pregnancy and pregnancy outcome Praveena K.R. 1, Pramod Kumar K.R. 2*, Prasuna K.R. 3, Krishna Kumar TV 4 1 Assistant Professor, Department of
More informationMaternal and perinatal outcome in antenatal women with hypothyroidism
Original Research Article Maternal and perinatal outcome in antenatal women with hypothyroidism Polumuru Usha Devi 1, Gundu Vanaja 1* 1 Assistant Professor of Obstetrics and Gynecology, Andhra Medical
More informationAdverse pregnancy outcome in Saudi women diagnosed with overt hypothyroidism during pregnancy, with and without thyroid peroxidase antibodies.
Adverse pregnancy outcome in Saudi women diagnosed with overt hypothyroidism during pregnancy, with and without thyroid peroxidase antibodies. Inass Taha Department of Medicine, Medical Collage, Taibah
More informationBiomedical Research 2017; 28 (1):
Biomedical Research 2017; 28 (1): 309-314 ISSN 0970-938X www.biomedres.info Association between the clinical classification of hypothyroidism and maternal and foetal outcomes, and the effects of levothyroxine
More informationThyroid Disease in Pregnancy: The Essentials. Elizabeth N. Pearce, MD, MSc
Thyroid Disease in Pregnancy: The Essentials Elizabeth N. Pearce, MD, MSc None Disclosures Case 1 A 31-year-old woman from Massachusetts is practicing a vegan diet. She is currently planning a pregnancy.
More informationClinical Study Further Evidence on the Role of Thyroid Autoimmunity in Women with Recurrent Miscarriage
International Endocrinology Volume 2012, Article ID 717185, 4 pages doi:10.1155/2012/717185 Clinical Study Further Evidence on the Role of Thyroid Autoimmunity in Women with Recurrent Miscarriage Natalia
More informationTSH should be measured in any women with symptoms of hypothyroidism. Screening of asymptomatic women is reviewed below. (See 'Screening' below.
Official reprint from UpToDate www.uptodate.com 2017 UpToDate Hypothyroidism during pregnancy: Clinical manifestations, diagnosis, and treatment Author: Douglas S Ross, MD Section Editors: David S Cooper,
More informationLecture title. Name Family name Country
Lecture title Name Family name Country Nguyen Thy Khue, MD, PhD Department of Endocrinology HCMC University of Medicine and Pharmacy, MEDIC Clinic Hochiminh City, Viet Nam Provided no information regarding
More informationOvert and subclinical hypothyroidism among Bangladeshi pregnant women and its effect on fetomaternal outcome
Bangladesh Med Res Counc Bull 21; : 52-57 Overt and subclinical hypothyroidism among Bangladeshi pregnant women and its effect on fetomaternal outcome Sharmeen M, Shamsunnahar A, Laita TR, Chowdhury SB
More informationCROSS TOWN ENDOCRINE CLUB. Alex S. Stagnaro-Green, M.D. THURSDAY, OCTOBER 22, 2009
CROSS TOWN ENDOCRINE CLUB Alex S. Stagnaro-Green, M.D. Professor of Medicine, Professor of Obstetrics & Gynecology Touro University College of Medicine Hackensack, New Jersey USC School of Medicine Visiting
More informationReview Article Think Thyroid - Think Life: Pregnancy with Thyroid Disorders
Chettinad Health City Medical Journal Muthukumaran Jayapaul* Consultant Endocrinologist, Arka Center for Hormonal Health, Chennai, India Dr. Muthu Kumaran Jayapaul is a Consultant Endocrinologist and also
More informationTHE TREATMENT OF HYPOTHYROIDISM IN PREGNANCY
2017 ILEX PUBLISHING HOUSE, Bucharest, Roumania http://www.jrdiabet.ro Rom J Diabetes Nutr Metab Dis. 24(2):155-160 doi: 10.1515/rjdnmd-2017-0020 THE TREATMENT OF HYPOTHYROIDISM IN PREGNANCY Rucsandra
More informationTHE PHARMA INNOVATION - JOURNAL Assessment of Antithyroperoxidase Antibodies and Thyroid Hormones Among Sudanese Pregnant Women
Received: 01-09-2013 Accepted: 30-09-2013 ISSN: 2277-7695 CODEN Code: PIHNBQ ZDB-Number: 2663038-2 IC Journal No: 7725 Vol. 2 No. 9 2013 Online Available at www.thepharmajournal.com THE PHARMA INNOVATION
More informationTo evaluate the influence of ferritin on thyroid hormones in second trimester antenatal cases in Perambalur District
Original Research Article To evaluate the influence of ferritin on thyroid hormones in second trimester antenatal cases in Perambalur District Nageshwari A 1, G. Kavitha 2* 1 Final year Postgraduate student,
More informationDownloaded from by guest on 18 September 2018
ORIGINAL ARTICLE Endocrine Care Assessment of Thyroid Function During First- Trimester Pregnancy: What Is the Rational Upper Limit of Serum TSH During the First Trimester in Chinese Pregnant Women? Chenyan
More informationSubclinical hypothyroidism and hypothyroidism in pregnancy
Subclinical hypothyroidism and hypothyroidism in pregnancy This statement has been developed and reviewed by the Women s Health Committee and approved by the RANZCOG Board and Council. A list of Women
More informationThyroid function after controlled ovarian hyperstimulation in women with and without the hyperstimulation syndrome
Thyroid function after controlled ovarian hyperstimulation in women with and without the hyperstimulation syndrome Kris Poppe, M.D., Ph.D., a David Unuane, M.D., a Miguel D Haeseleer, M.D., a Herman Tournaye,
More informationUniversal Screening Versus Case Finding for Detection and Treatment of Thyroid Hormonal Dysfunction During Pregnancy
J Clin Endocrin Metab. First published ahead of print February 3, 2010 as doi:10.1210/jc.2009-2009 ORIGINAL ARTICLE Endocrine Care Universal Screening Versus Case Finding for Detection and Treatment of
More informationHow to manage hypothyroid disease in pregnancy
For mass reproduction, content licensing and permissions contact Dowden Health Media. FIRST OF 2 PARTS How to manage hypothyroid disease in pregnancy Pregnancy complicated by hypothyroidism puts mother
More informationThyroid Dysfunction during Pregnancy: A Review of the Current Guidelines
, pp: 130-136 (ISSN: 2455-1716) Impact Factor 2.4 MARCH-2016 Review Article (Open access) Thyroid Dysfunction during Pregnancy: A Review of the Current Guidelines Mustafa Al Abousi* Department of Endocrinology,
More informationDAGNOSIS AND TREATMENT OF THYROID GLAND DISEASES IN PREGNANCY GUIDELINE AND RECOMMENDATIONS
Svetlana Spremovic-Radjenovic 1 DAGNOSIS AND TREATMENT OF THYROID GLAND DISEASES IN PREGNANCY GUIDELINE AND RECOMMENDATIONS The field referred to thyroid gland diseases and pregnancy has recorded the fast
More informationBeneficial effects on pregnancy outcomes of thyroid hormone replacement for subclinical hypothyroidism
The University of Notre Dame Australia ResearchOnline@ND Medical Papers and Journal Articles School of Medicine 2017 Beneficial effects on pregnancy outcomes of thyroid hormone replacement for subclinical
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,100 116,000 120M Open access books available International authors and editors Downloads Our
More informationThyroid function in pregnancy
Published Online December 23, 2010 Thyroid function in pregnancy John H. Lazarus * Centre for Endocrine and Diabetes Sciences, Cardiff University School of Medicine, University Hospital of Wales, Heath
More informationDiagnostic Significance of Subclinical Hypothyroidism in Health Check-ups
ORIGINAL ARTICLES Diagnostic Significance of Subclinical Hypothyroidism in Health Check-ups Saori Hashimoto 1 Katsuji Ikekubo 1 Kanako Ika 1 Yuriko Kurahashi 1 Kaoru Takahashi 1 Yoshindo Kida 1 Tsutomu
More informationReview Article Screening for Maternal Thyroid Dysfunction in Pregnancy: A Review of the Clinical Evidence and Current Guidelines
Thyroid Research Volume 2013, Article ID 851326, 8 pages http://dx.doi.org/10.1155/2013/851326 Review Article Screening for Maternal Thyroid Dysfunction in Pregnancy: A Review of the Clinical Evidence
More informationHigher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death
European Journal of Endocrinology (2009) 160 985 991 ISSN 0804-4643 CLINICAL STUDY Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death N
More informationUpdate on Gestational Thyroid Disease. Aidan McElduff The Discipline of Medicine, The University of Sydney
IADPSG 2016 Update on Gestational Thyroid Disease Aidan McElduff The Discipline of Medicine, The University of Sydney IADPSG 2016 DISCLOSURES and AIM Nil to disclose Aim: to provide an overview 2017 Guidelines
More informationA prospective observational study of thyroid dysfunctions during pregnancy in a tertiary care hospital
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Chunchaiah S et al. Int J Reprod Contracept Obstet Gynecol. 2016 Nov;5(11):3683-3689 www.ijrcog.org pissn 2320-1770 eissn
More informationResearch Article Impaired Fertility Associated with Subclinical Hypothyroidism and Thyroid Autoimmunity: The Danish General Suburban Population Study
Pregnancy Volume 2015, Article ID 132718, 6 pages http://dx.doi.org/10.1155/2015/132718 Research Article Impaired Fertility Associated with Subclinical Hypothyroidism and Thyroid Autoimmunity: The Danish
More informationThe Presence of Thyroid Autoantibodies in Pregnancy
The Presence of Thyroid Autoantibodies in Pregnancy Dr. O Sullivan does not have any financial relationships with any commercial interests. KATIE O SULLIVAN, MD FELLOW, ADULT/PEDIATRIC ENDOCRINOLOGY ENDORAMA
More informationRole of anti-thyroid peroxidase antibodies in adverse pregnancy outcomes
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Gupta A et al. Int J Reprod Contracept Obstet Gynecol. 2016 Sept;5(9):3001-3005 www.ijrcog.org pissn 2320-1770 eissn 2320-1789
More informationStatus of Thyroid Peroxidase Antibodies in Pregnant Women and Association with Obstetric and Perinatal Outcomes in Tertiary Care Center
DOI: 10.7860/NJLM/2017/29019:2255 Obstetrics and Gynaecology Section Original Article Status of Thyroid Peroxidase Antibodies in Pregnant Women and Association with Obstetric and Perinatal Outcomes in
More informationEsther Briganti. Fetal And Maternal Health Beyond the Womb: hot topics in endocrinology and pregnancy. Endocrinologist and Clinician Researcher
Fetal And Maternal Health Beyond the Womb: hot topics in endocrinology and pregnancy Esther Briganti Endocrinologist and Clinician Researcher Director, Melbourne Endocrine Associates Associate Professor,
More informationReview Article Levothyroxine Treatment in Pregnancy: Indications, Efficacy, and Therapeutic Regimen
SAGE-Hindawi Access to Research Journal of Thyroid Research Volume 2011, Article ID 843591, 12 pages doi:10.4061/2011/843591 Review Article Levothyroxine Treatment in Pregnancy: Indications, Efficacy,
More informationHypothyroidism and pregnancy loss: comparison with hyperthyroidism and diabetes in a Danish population-based study
Clinical Endocrinology (2016) 85, 962 970 doi: 10.1111/cen.13136 ORIGINAL ARTICLE Hypothyroidism and pregnancy loss: comparison with hyperthyroidism and diabetes in a Danish population-based study Stine
More informationThyroid function testing in pregnancy: 2017 ATA guidelines update. Dr Simon Forehan
Thyroid function testing in pregnancy: 2017 ATA guidelines update Dr Simon Forehan Several factors are known to tax gravid thyroid economy: Increased plasma volume TBG pool increased Renal clearance Feto-placental
More informationEvaluation of serum ferritin and thyroid function in the second trimester of pregnancy
2018, 65 (1), 75-82 Original Evaluation of serum ferritin and thyroid function in the second trimester of pregnancy Leqi He 1) *, Chunmei Shen 1) *, Yanan Zhang 2), Zaoping Chen 2), Heyuan Ding 2), Jun
More informationPrevalence of thyroid disorder in pregnancy and pregnancy outcome
Original Research Article Prevalence of thyroid disorder in pregnancy and pregnancy outcome Rama Saraladevi 1*, T Nirmala Kumari 1, Bushra Shreen 2, V. Usha Rani 3 1 Associate Professor, 2 Senior Resident,
More informationThyroxine treatment may be useful for subclinical hypothyroidism in patients with female infertility
Endocrine Journal 2015, 62 (1), 87-92 Original Thyroxine treatment may be useful for subclinical hypothyroidism in patients with female infertility Waka Yoshioka, Nobuyuki Amino, Akane Ide, Shino Kang,
More informationResearch Article Trimester- and Assay-Specific Thyroid Reference Intervals for Pregnant Women in China
International Endocrinology Volume 2016, Article ID 3754213, 5 pages http://dx.doi.org/10.1155/2016/3754213 Research Article Trimester- and Assay-Specific Thyroid Reference Intervals for Pregnant Women
More informationSubclinical Hypothyroidism and Isolated Hypothyroxinemia during Pregnancy and Their Association with Pregnancy Outcome: A 2-Year Study
Open Journal of Obstetrics and Gynecology, 2017, 7, 693-701 http://www.scirp.org/journal/ojog ISSN Online: 2160-8806 ISSN Print: 2160-8792 Subclinical Hypothyroidism and Isolated Hypothyroxinemia during
More informationReference Values for TSH and Free Thyroid Hormones in Healthy Pregnant Women in Poland: A Prospective, Multicenter Study
Clinical Thyroidology / Original Paper Received: February 16, 2016 Accepted after revision: August 11, 2016 Published online: February 3, 2017 Reference Values for TSH and Free Thyroid Hormones in Healthy
More informationBELIEVE MIDWIFERY SERVICES
TITLE: THYROID DISEASE IN PREGNANCY EFFECTIVE DATE: July, 2013 POLICY STATEMENT: Pregnancy changes significantly the values influenced by the serum thyroid binding hormone level (i.e., total thyroxine,
More informationmeta-analysis of randomised
To cite: Yamamoto JM, Benham JL, Nerenberg KA, et al. Impact of levothyroxine therapy on obstetric, neonatal and childhood outcomes in women with subclinical hypothyroidism diagnosed in pregnancy: a systematic
More informationNIH Public Access Author Manuscript Ther Drug Monit. Author manuscript; available in PMC 2013 April 14.
NIH Public Access Author Manuscript Published in final edited form as: Ther Drug Monit. 2006 February ; 28(1): 8 11. Thyroid Function Testing in Pregnancy and Thyroid Disease: Trimester-specific Reference
More informationReview Article Management of Hyperthyroidism in Pregnancy: Comparison of Recommendations of American Thyroid Association and Endocrine Society
Thyroid Research Volume 2013, Article ID 878467, 6 pages http://dx.doi.org/10.1155/2013/878467 Review Article Management of Hyperthyroidism in Pregnancy: Comparison of of American Thyroid Association and
More informationReference intervals are derived from the statistical distribution of values in the general healthy population.
Position Statement Subject: Thyroid Function Testing for Adult Diagnosis and Monitoring Approval Date: July 2017 Review Date: July 2019 Review By: Chemical AC, Board of Directors Number: 1/2017 Introduction:
More informationThyrotoxicosis in Pregnancy: Diagnose and Management
Thyrotoxicosis in Pregnancy: Diagnose and Management Yuanita Asri Langi email: meralday@yahoo.co.id Endocrinology & Metabolic Division, Internal Medicine Department, Prof.dr.R.D. Kandou Hospital/ Sam Ratulangi
More informationUniversal TSH screening to detect hypothyroidism in pregnancy : a comprehensive review
The University of Toledo The University of Toledo Digital Repository Master s and Doctoral Projects Universal TSH screening to detect hypothyroidism in pregnancy : a comprehensive review Andrea M. Fox
More informationUnderstanding the Thyroid and Pregnancy
FERTILITY nurses first Understanding the Thyroid and Pregnancy Tamara Tobias, ARNP Human chorionic gonadotropin (hcg) and estrogen are two hormones that play an important role during pregnancy. They can,
More informationHypothyroidism in pregnancy
Review Article Page 1 of 8 Hypothyroidism in pregnancy Fahimeh Ramezani Tehrani, Samira Behboudi-Gandevani Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid
More informationPLACE OF SELENIUM IN THE TREATMENT OF THYROID DISEASES
VII, 2013, 2 27, PLACE OF SELENIUM IN THE TREATMENT OF THYROID DISEASES D. Gavrailova Faculty of Public Health, Medical University So a : (Se).,. Se, - (, )., Se., Se -. :,,, :,, Summary: The essential
More informationClinical Study Risk-Based Screening for Thyroid Dysfunction during Pregnancy
Pregnancy Volume 2013, Article ID 619718, 5 pages http://dx.doi.org/10.1155/2013/619718 Clinical Study Risk-Based Screening for Thyroid Dysfunction during Pregnancy Masanao Ohashi, 1 Seishi Furukawa, 2
More informationImpact of borderline subclinical hypothyroidism on subsequent pregnancy outcome in women with unexplained recurrent pregnancy loss
doi:10.1111/jog.13319 J. Obstet. Gynaecol. Res. Vol. 43, No. 6: 1014 1020, June 2017 Impact of borderline subclinical hypothyroidism on subsequent pregnancy outcome in women with unexplained recurrent
More informationScreening and subsequent management for thyroid dysfunction pre-pregnancy and during pregnancy for improving maternal and infant health(review)
Cochrane Database of Systematic Reviews Screening and subsequent management for thyroid dysfunction pre-pregnancy and during pregnancy for improving maternal and infant health(review) SpencerL,BubnerT,BainE,MiddletonP
More informationEffect of mildly elevated thyroid-stimulating hormone during the first trimester on adverse pregnancy outcomes
Li et al. BMC Endocrine Disorders (2018) 18:64 https://doi.org/10.1186/s12902-018-0294-7 RESEARCH ARTICLE Open Access Effect of mildly elevated thyroid-stimulating hormone during the first trimester on
More information2004 Where Do We Go from Here? Summary of Working Group Discussions on Thyroid Function and Gestational Outcomes
THYROID Volume 15, Number 1, 2005 Mary Ann Liebert, Inc. 2004 Where Do We Go from Here? Summary of Working Group Discussions on Thyroid Function and Gestational Outcomes Joseph G. Hollowell, 1 Stephen
More informationThyroid function after assisted reproductive technology in women free of thyroid disease
Thyroid function after assisted reproductive technology in women free of thyroid disease Kris Poppe, M.D., a Daniel Glinoer, M.D., Ph.D., b Herman Tournaye, M.D., Ph.D., c Johan Schiettecatte, c Patrick
More informationPreconception management of thyroid dysfunction
Received: 17 February 2018 Revised: 22 April 2018 Accepted: 23 April 2018 DOI: 10.1111/cen.13731 REVIEW ARTICLE Preconception management of thyroid dysfunction Onyebuchi E. Okosieme 1,2 Ishrat Khan 1 Peter
More informationHypothyroidism. Definition:
Definition: Hypothyroidism Primary hypothyroidism is characterized biochemically by a high serum thyroidstimulating hormone (TSH) concentration and a low serum free thyroxine (T4) concentration. Subclinical
More informationMaternal outcome in thyroid dysfunction
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Manju VK et al. Int J Reprod Contracept Obstet Gynecol. 2017 Jun;6(6):2361-2365 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20172313
More informationPerinatal Outcome of Children Born to Mothers with Thyroid Dysfunction or Antibodies: A Prospective Population-Based Cohort Study
ORIGINAL Endocrine ARTICLE Care Perinatal Outcome of Children Born to Mothers with Thyroid Dysfunction or Antibodies: A Prospective Population-Based Cohort Study Tuija Männistö, Marja Vääräsmäki, Anneli
More informationInfluence of screening and intervention of hyperthyroidism on pregnancy outcome
European Review for Medical and Pharmacological Sciences 2017; 21: 1932-1937 Influence of screening and intervention of hyperthyroidism on pregnancy outcome Y. WANG, X.-L. SUN, C.-L. WANG, H.-Y. ZHANG
More informationThe influence of thyroid disorders on adverse pregnancy outcomes
The influence of thyroid disorders on adverse pregnancy outcomes Rosa Vissenberg THE INFLUENCE OF THYROID DISORDERS ON ADVERSE PREGNANCY OUTCOMES Rosa Vissenberg Financial support for printing of this
More informationMaternal thyroid disease in the Danish National Birth Cohort: prevalence and risk factors
Clinical Study S L Andersen and others Thyroid disease in pregnancy 174:2 203 212 Maternal thyroid disease in the Danish National Birth Cohort: prevalence and risk factors Stine Linding Andersen 1,2, Jørn
More informationDecreased Birth Weight, Length, and Head Circumference in Children Born by Women Years After Treatment for Hyperthyroidism
ORIGINAL Endocrine ARTICLE Research Decreased Birth Weight, Length, and Head Circumference in Children Born by Women Years After Treatment for Hyperthyroidism Hans Ohrling, Ove Törring, Li Yin, Anastasia
More informationTable 1: Thyroid panel. Result (reference interval) TSH 89.5 miu/l ( ) Total T4 5.2 µg/dl ( ) T3 uptake 39% (22-35)
Introduction Thyroid disease is the second most common endocrine disorder (behind diabetes), and its prevalence increases with increasing age. The incidence of newly diagnosed thyroid cancer is increasing
More informationHolistic Medicine for the 21 st Century
Holistic Medicine for the 21 st Century David Brownstein, M.D. Center for Holistic Medicine 5821 W. Maple Rd. Ste. 192 West Bloomfield, MI 48322 248.851.1600 www.drbrownstein.com Overcoming Thyroid Disorders
More informationThe e-supplementary online content file_1: The Study Protocol
The e-supplementary online content file_1: The Study Protocol Supplement1_English: English Version of the Study Protocol Supplement1_Chinese: Chinese Version of the Study Protocol Supplement1_Ethical Approval:
More informationIodine and Thyroid Hormones
Iodine and Thyroid Hormones Iodine and Thyroid Hormones feed-back Iodine Deficiency Characteristics Iodine Deficiency None Mild Mode Severe Median urine iodine >100 50-99 20-49
More informationBMJ Open is committed to open peer review. As part of this commitment we make the peer review history of every article we publish publicly available.
is committed to open peer review. As part of this commitment we make the peer review history of every article we publish publicly available. When an article is published we post the peer reviewers comments
More informationLevothyroxine liquid solution versus tablet form for replacement treatment in pregnant women
Levothyroxine liquid solution versus tablet form for replacement treatment in pregnant women Carlo Cappelli 1, Roberto Negro 2, Ilenia Pirola 1, Elena Gandossi 1, Barbara Agosti 1, Maurizio Castellano
More informationStudy of the Relationship between Anti-Peroxidase Antibody and Miscarriage, Preterm Labor and IUGR in Egyptian Pregnant Women
Open Journal of Obstetrics and Gynecology, 2017, 7, 494-502 http://www.scirp.org/journal/ojog ISSN Online: 2160-8806 ISSN Print: 2160-8792 Study of the Relationship between Anti-Peroxidase Antibody and
More informationSubclinical Hypothyroidism
Subclinical Hypothyroidism Key Clinical Points Subclinical hypothyroidism is defined as an elevated thyrotropin level with a normal free thyroxine (T 4 ) level. To confirm the diagnosis, a transient increase
More informationTiming and Magnitude of Increases in Levothyroxine Requirements during Pregnancy in Women with Hypothyroidism
original article Timing and Magnitude of Increases in Levothyroxine Requirements during Pregnancy in Women with Hypothyroidism Erik K. Alexander, M.D., Ellen Marqusee, M.D., Jennifer Lawrence, M.D., Petr
More informationHypothyroidism and Hyperthyroidism. Paul V. Tomasic, MD, MS, FACP, FACE Nevada AACE EFNE & Annual Meeting October 6, 2018
Hypothyroidism and Hyperthyroidism Paul V. Tomasic, MD, MS, FACP, FACE Nevada AACE EFNE & Annual Meeting October 6, 2018 Disclosures: None related to this program or presentation Objectives: Hypothyroidism
More informationStudy of thyroid profile during pregnancy
Original Research Article Study of thyroid profile during pregnancy Raghav Nepalia 1*, Renuka Z Lal 2 1 Sr. Demonstrator, 2 Assistant Professor Department of Biochemistry, RNT Medical College, Udaipur,
More informationProtocol. This trial protocol has been provided by the authors to give readers additional information about their work.
Protocol This trial protocol has been provided by the authors to give readers additional information about their work. Protocol for: Lazarus JH, Bestwick JP, Channon S, et al. Antenatal thyroid screening
More informationJMSCR Vol 04 Issue 03 Page March 2016
www.jmscr.igmpublication.org Impact Factor 5.244 Index Copernicus Value: 5.88 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: http://dx.doi.org/10.18535/jmscr/v4i3.60 Thyroid Dysfunction and Pregnancy Outcome
More informationUpdate In Hypothyroidism
Update In Hypothyroidism CME Away India & Sri Lanka March 23 - April 7, 2018 Richard A. Bebb MD, ABIM, FRCPC Consultant Endocrinologist Medical Subspecialty Institute Cleveland Clinic Abu Dhabi Copyright
More informationOver the last 2 decades, the link between maternal thyroid
ORIGINAL Endocrine ARTICLE Research Maternal Thyroid Function in the First Twenty Weeks of Pregnancy and Subsequent Fetal and Infant Development: A Prospective Population- Based Cohort Study in China Pu-Yu
More information